AU471022B2 - Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione - Google Patents

Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione

Info

Publication number
AU471022B2
AU471022B2 AU36959/71A AU3695971A AU471022B2 AU 471022 B2 AU471022 B2 AU 471022B2 AU 36959/71 A AU36959/71 A AU 36959/71A AU 3695971 A AU3695971 A AU 3695971A AU 471022 B2 AU471022 B2 AU 471022B2
Authority
AU
Australia
Prior art keywords
pregnane
dione
hydroxy
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU36959/71A
Other versions
AU3695971A (en
Inventor
Davis Derek Roger Pearce Paul Connor Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of AU3695971A publication Critical patent/AU3695971A/en
Application granted granted Critical
Publication of AU471022B2 publication Critical patent/AU471022B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU36959/71A 1970-12-17 1971-12-16 Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione Expired AU471022B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB60067/70 1970-12-17
GB6006770A GB1379730A (en) 1970-12-17 1970-12-17 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AU3695971A AU3695971A (en) 1973-06-21
AU471022B2 true AU471022B2 (en) 1976-04-08

Family

ID=10484946

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36959/71A Expired AU471022B2 (en) 1970-12-17 1971-12-16 Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione

Country Status (11)

Country Link
AT (1) AT333963B (en)
AU (1) AU471022B2 (en)
BE (1) BE776788A (en)
CA (1) CA970281A (en)
DE (1) DE2162593A1 (en)
FR (1) FR2118120B1 (en)
GB (1) GB1379730A (en)
IE (1) IE36705B1 (en)
IL (1) IL38375A (en)
NL (1) NL7117255A (en)
ZA (1) ZA718463B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581735A (en) * 1978-12-14 1980-06-20 Kao Corp Emulsifier composition
JP2655190B2 (en) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 Ointment containing corticosteroid
SE9302295D0 (en) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab NEW PHARMACEUTICAL COMPOSITION
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
WO2020123551A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL91070C (en) * 1900-01-01
DE1262509B (en) * 1962-04-19 1968-03-07 Hoechst Ag Process for the production of aqueous solutions of steroid hormones
FR6555M (en) * 1967-05-03 1968-12-23

Also Published As

Publication number Publication date
FR2118120B1 (en) 1976-04-16
IE36705L (en) 1972-06-17
FR2118120A1 (en) 1972-07-28
IE36705B1 (en) 1977-02-02
BE776788A (en) 1972-06-16
IL38375A0 (en) 1972-02-29
IL38375A (en) 1976-07-30
NL7117255A (en) 1972-06-20
ZA718463B (en) 1973-08-29
CA970281A (en) 1975-07-01
ATA1082571A (en) 1976-04-15
DE2162593A1 (en) 1972-07-06
GB1379730A (en) 1975-01-08
AU3695971A (en) 1973-06-21
AT333963B (en) 1976-12-27

Similar Documents

Publication Publication Date Title
CA955252A (en) Pharmaceutical compositions
AU450603B2 (en) New pharmaceutical compositions
AU471022B2 (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
CA968273A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING M-TYROSINE AND .alpha.-HYDRAZINO-3,4-DIHYDROXYPHENYLPROPIONIC ACID
AU2682871A (en) Pharmaceutical compositions
CA969953A (en) Pharmaceutical compositions
CA958643A (en) Pharmaceutical compositions containing cyclobenzaprine
AU3017971A (en) Pharmaceutical composition
AU452135B2 (en) Pharmaceutical compositions
IL36549A (en) Substituted imidazolines-(2),their preparation and pharmaceutical compositions containing them
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
CA943462A (en) Pharmaceutical compositions containing 2-(2,6-dichlorophenyl-amino)-1,3-diazacyclopentene-(2)
CA943126A (en) 4,14-estradiene compounds
IL36397A0 (en) New n-vinyl-quinolones,processes for the preparation thereof and pharmaceutical compositions containing the same
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid
CA838088A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE
CA822642A (en) Pharmaceutical compositions containing 2,6-dichloro-benzene compounds
CA854688A (en) 2,6-dicyanotrichloropyridine-containing compositions
IL35232A (en) Anticonvulsive pharmaceutical compositions containing 3,3-dimethyl-1-phenyl-1-phthalane-acetamide
AU449539B2 (en) Pharmaceutical compositions
AU458685B2 (en) Pharmaceutical compositions
CA845684A (en) Pharmaceutical compositions
AU456863B2 (en) Pharmaceutical compositions
CA851190A (en) Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions
CA955527A (en) Shampoo composition